Repligen (RGEN) Inventory (2011 - 2026)

Repligen (RGEN) has reported Inventory for 16 consecutive years, with $186.6 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Inventory rose 19.72% year-over-year to $186.6 million in Q2 2026; TTM through Jun 2026 was $186.6 million, a 19.72% increase from a year earlier, with the FY2025 full-year figure at $170.5 million, up 19.23% from the prior year.
• Inventory was $186.6 million for Q2 2026 at Repligen, up from $179.3 million in the prior quarter.
• Over five years, Inventory peaked at $244.7 million in Q1 2023 and troughed at $143.0 million in Q4 2024.
• A 5-year average of $197.4 million and a median of $194.3 million in 2024 frame the typical range for Inventory.
• Across the five-year window, Inventory jumped 95.19% in 2022 and slipped 29.34% in 2024, its largest moves.
• Over 5 years, Inventory stood at $238.3 million in 2022, then declined by 15.09% to $202.3 million in 2023, then fell by 29.34% to $143.0 million in 2024, then grew by 19.23% to $170.5 million in 2025, then advanced by 9.47% to $186.6 million in 2026.
• The last three Inventory figures came in at $186.6 million (Q2 2026), $179.3 million (Q1 2026), and $170.5 million (Q4 2025), per Business Quant data.